Benzinga's Top Upgrades

Loading...
Loading...
Analysts at Credit Suisse upgraded Cubist Pharmaceuticals
CBST
from “neutral” to “outperform.” The target price for Cubist Pharmaceuticals has been raised from $56 to $69. Cubist's shares closed at $57.00 yesterday. Analysts at Benchmark upgraded Open Text
OTEX
from “hold” to “buy.” The target price for Open Text is set to $85. Open Text's shares closed at $67.46 yesterday. Analysts at Piper Jaffray upgraded Questcor Pharmaceuticals
QCOR
from “neutral” to “overweight.” The target price for Questcor Pharmaceuticals has been raised from $41 to $74. Questcor's shares closed at $51.91 yesterday. Analysts at JP Morgan upgraded Compass Minerals International
CMP
from “underweight” to “neutral” The target price for Compass Minerals International has been raised from $65 to $66. Compass Minerals International's shares closed at $73.06 yesterday.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesAnalyst Ratingstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...